FIERCEHEALTHCARE: Prices for top-selling drugs appear immune to common market forces: study

By Matt Kuhrt

When it comes to concerns over the rising costs of prescription drugs, it’s not just an isolated few that should be grabbing the headlines.

A new study published in the Journal of the American Medical Association, which examined prices for the 49 top-selling drugs between January 2012 and December 2017, found virtually all of them rose in price on a regular basis. The median price among those drugs rose 76% over the time period, and 78% of the drugs in the study saw price hikes of at least 50%. More than 4 of 5 products in the study more than doubled in price.

“You might see an article that says prices are rising—insulin, EpiPens, those are major news stories—and you might think it’s just a couple drugs. We looked at every popular drug we could find and the trends were near-universal,” says the study’s lead author Nathan Wineinger, Ph.D., of the Scripps Research Institute.

Continue reading at FierceHealthcare…